Home›Research›Compare›CJC-1295 DAC vs IGF-2
Peptide ComparisonCJC-1295 DAC vs IGF-2
Both are GH / IGF Axis peptides.
CJC-1295 DAC
CJC-1295 with DAC
Half-life: 6–8 days
1 providers listed
IGF-2
Insulin-like Growth Factor 2
Half-life: ~10-20 minutes
No providers listed yet
CJC-1295 DAC carries stronger published evidence (RCT, 1 key studies) than IGF-2 (Case series, 6); both are research compounds.
CJC-1295 DAC
Half-life
6–8 days
IGF-2
Half-life
~10-20 minutes
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | CJC-1295 DAC |
| Less frequent dosing (longer half-life) | CJC-1295 DAC |
| More provider options (1 vs 0) | CJC-1295 DAC |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
CJC-1295 DAC
IGF-2
IGF-2
IGF-2-mediated hypoglycemia in a patient with a phyllodes tumor of the breast: a rare presentation of non-isl…
Proteomics and ex vivo plaque culture identify the insulin-like growth factor axis as a potential regulator o…
TGF-β inhibits muscle differentiation by blocking autocrine signaling pathways initiated by IGF-II
Autocrine growth factor signaling by insulin-like growth factor-II mediates MyoD-stimulated myocyte maturation
+2 more
About CJC-1295 DAC
CJC-1295 DAC is a GHRH analog carrying a Drug Affinity Complex (DAC) modification that binds covalently to circulating albumin, greatly extending its plasma half-life relative to unmodified or short-acting GHRH analogs. Through this albumin binding it acts as a long-lasting agonist at pituitary GHRH receptors, associated in research with sustained growth hormone and downstream IGF-1 elevation. This contrasts with the non-DAC form (Mod GRF 1-29), whose action is measured in minutes rather than days.
About IGF-2
Binds IGF-1R and insulin receptor variant A; promotes anabolic signaling in muscle and fat; activates PI3K/Akt/mTOR pathway; different receptor binding profile than IGF-1
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
CJC-1295 DAC
Class-based (investigational)
Research protocols routinely measure IGF-1 to track GH axis activity before and during use. Fasting glucose and insulin are monitored because GH elevation can reduce insulin sensitivity over time.
global — WADA
This compound falls under WADA Prohibited List category S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), prohibited at all times for competing athletes.
sourceIGF-2
Under clinical review
Being verified by our medical team before we display contraindications for this peptide.
CJC-1295 DAC
IGF-2
Not enough vendor pricing yet.
Where to source these peptides
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More GH / IGF Axis Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated August 26, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). CJC-1295 DAC vs IGF-2 — Per-mg Price Comparison. Retrieved September 11, 2026, from https://peptidebase.io/peptides/compare/cjc-1295-dac/igf-2